カテゴリー： 世界, 医療/バイオ, Grand View Research

世界のポリクローナル抗体市場2023-2030：製品別（一次、二次）、用途別（生物医学研究、診断）、由来別（ウサギ、ヤギ）、エンドユーザー別、地域別

【英語タイトル】Polyclonal Antibodies Market Size, Share & Trends Analysis Report By Product (Primary, Secondary), By Application (Biomedical Research, Diagnostics), By Source (Rabbit, Goats), By End-user, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23JUN089）・商品コード：GRV23JUN089
・発行会社（調査会社）：Grand View Research
・発行日：2023年5月22日
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Grand View Research社の市場調査書によると、世界のポリクローナル抗体市場規模が、予測期間中（2023年～2030年）に年平均5.01％増加し、2030年までに22.1億ドルへ達すると見込まれています。本調査書では、ポリクローナル抗体の世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向、製品別（一次抗体、二次抗体）分析、用途別（生物医学研究、診断）分析、由来別（ウサギ、ヤギ、羊、マウス、その他）分析、エンドユーザー別（製薬・バイオテクノロジー企業、病院・診断センター、学術・研究センター）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などについて調査・分析し、まとめています。なお、こちらに掲載されている企業情報には、THERMO FISHER SCIENTIFIC INC.、MERCK KGAA、ABCAM PLC.、PROTEOGENIX、PROTEINTECH GROUP, INC.、BIO-RAD LABORATORIES INC.、BPS BIOSCIENCE, INC.、R&D SYSTEMS, INC.、AGILENT TECHNOLOGIES, INC.、ATLAS ANTIBODIES、CUSABIO TECHNOLOGY LLC、ROCKLAND IMMUNOCHEMICALS, INC.などが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向
・世界ポリクローナル抗体の市場規模：製品別
- 一次抗体の市場規模
- 二次抗体の市場規模
・世界ポリクローナル抗体の市場規模：用途別
- 生物医学研究における市場規模
- 診断における市場規模
・世界ポリクローナル抗体の市場規模：由来別
- ウサギ由来ポリクローナル抗体の市場規模
- ヤギ由来ポリクローナル抗体の市場規模
- 羊由来ポリクローナル抗体の市場規模
- マウス由来ポリクローナル抗体の市場規模
- その他由来ポリクローナル抗体の市場規模
・世界ポリクローナル抗体の市場規模：エンドユーザー別
- 製薬・バイオテクノロジー企業における市場規模
- 病院・診断センターにおける市場規模
- 学術・研究センターにおける市場規模
・世界ポリクローナル抗体の市場規模：地域別
- 北米のポリクローナル抗体市場規模
- ヨーロッパのポリクローナル抗体市場規模
- アジア太平洋のポリクローナル抗体市場規模
- 中南米のポリクローナル抗体市場規模
- 中東・アフリカのポリクローナル抗体市場規模
・競争状況

ポリクローナル抗体市場の成長と動向

Grand View Research社の最新レポートによると、世界のポリクローナル抗体市場規模は2030年までに22億1000万米ドルに達すると予測されています。同市場は2023年から2030年にかけて年平均成長率5.01%で拡大すると予測されています。抗体をベースとした医薬品の生産における技術進歩の増加、癌などの感染症や慢性疾患の世界的な蔓延の増加、バイオ医薬品の研究開発活動の増加が業界の主な促進要因となっています。さらに、ポリクローナル抗体（pAbs）は、定量的・定性的な生物学的研究や、いくつかの診断検査に広く利用されています。

ポリクローナル抗体の使用はCOVID-19患者の治療に好影響を与えており、これらの治療法は入院率を低下させ、軽症から中等症の患者の転帰を改善することが研究で示されています。さらに、pAbsの開発はCOVID-19に対する免疫反応の理解を深めるのに役立ち、将来的にはより効果的な治療法やワクチンの開発につながると予測されています。このように、COVID-19の流行はpAbs市場に大きな影響を与えています。

診断、治療、研究など様々な用途でポリクローナル抗体の開発と使用を支援・促進する政府のイニシアチブがいくつかあります。これらのイニシアチブは、医療成果の向上、技術革新の促進、バイオテクノロジーや製薬産業の成長支援を目的としています。さらに、多くの政府もpAbs市場における学術機関、研究機関、業界関係者の連携を促進するためのイニシアチブを取っています。例えば、2020年5月、カナダ政府はAbCellera社に1億7500万米ドルを投資し、抗体治療検査や抗体構築施設の生産を支援しています。このように、政府の様々な取り組みがpAbs市場の需要を増加させると予想されています。

ポリクローナル抗体市場レポートハイライト

– 製品別では、高感度とシグナル増幅の質の向上により、二次抗体セグメントが2022年の収益シェアで56.14%を占め、業界の需要を増加させました。

– エンドユーザー別では、病院・診断センターセグメントが2022年に59.81%の収益シェアを占めました。この背景には、診断センターにおけるpAbsベースのアッセイに対する需要の増加、慢性疾患や感染症の流行の増加があります。

– 用途別では、診断分野が2022年に59.81%の売上シェアを占めました。pAbsは標的分子のエピトープを認識する能力があるため、血球凝集アッセイや診断に最適な試薬とみなされています。従って、用途セグメントにおける診断薬需要が増加しています。

– 由来別では、ウサギセグメントが2022年の売上シェアで50.69%を占めています。ウサギ由来のAbsは特異性が高く、ピコモル濃度でさまざまなタンパク質に結合できます。したがって、ウサギ由来Absの需要は今後増加すると予想されます。

– 2022年には、技術や医療インフラの進歩など様々な要因から、北米が38.62%以上の売上シェアを占めました。バイオテクノロジーや製薬業界のプレーヤーが多数存在することから、様々な抗体医薬の研究開発が活発化し、市場の成長が期待されます。

– 予測期間中のCAGRは9.67%で、アジア太平洋地域が最も急成長しています。慢性疾患の有病率の増加と個別化医療に対する需要の高まりが市場の急成長に拍車をかけると予想されます。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Product Segment
1.1.1.2 Application Segment
1.1.1.3 Source Segment
1.1.1.4 End-Use Segment
1.2 Information Procurement
1.2.1 Market Formulation & Data Visualization
1.2.2 Data Validation & Publishing
1.3 Research Assumptions
1.4 Research Methodology
1.4.1 Purchased Database
1.4.2 Gvr’s Internal Database
1.4.3 Secondary Sources
1.4.5 Primary Research
1.4.6 Details Of Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity Flow Approach
1.8 List Of Secondary Sources
1.9 Global Market: Cagr Calculation
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot 1
2.3 Segment Snapshot 2
2.4 Competitive Landscape Snapshot
Chapter 3 Polyclonal Antibodies Market Variables and Trends
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Increasing Prevalence Of Chronic And Infectious Diseases
3.2.1.2 Increasing Biopharmaceutical R&D Activities
3.2.1.3 Growing Demand For Personalized Medicines
3.2.1.4 Increasing Technological Advancements
3.2.2 Market Restraint Impact Analysis
3.2.2.1 Stringent regulations and ethical concerns regarding polyclonal antibody production
3.3 Impact of COVID-19 Pandemic
3.4 Industry Analysis Tools
3.4.1 Porter’s Analysis
3.4.2 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
Chapter 4 Polyclonal Antibodies Market: Product Estimates & Trend Analysis
4.1 Product Movement Analysis & Market Share, 2022 & 2030
4.2 Polyclonal Antibodies Market Estimates & Forecast, By Product (USD Million)
4.3 Primary Antibodies
4.3.1 Global Primary Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
4.4 Secondary Antibodies
4.4.1 Global Secondary Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 5 Polyclonal Antibodies Market: Application Estimates & Trend Analysis
5.1 Application Movement Analysis & Market Share, 2022 & 2030
5.2 Polyclonal Antibodies Market Estimates & Forecast, By Application (USD Million)
5.3 Biomedical Research
5.3.1 Global Biomedical Research Market Estimates And Forecasts, 2018 – 2030 (USD Million)
5.4 Diagnostics
5.4.1 Global Diagnostics Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 6 Polyclonal Antibodies Market: Source Estimates & Trend Analysis
6.1 Source Movement Analysis & Market Share, 2022 & 2030
6.2 Polyclonal Antibodies Market Estimates & Forecast, By Source (USD Million)
6.3 Rabbits
6.3.1 Global Rabbits Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.4 Goats
6.4.1 Global Goats Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.5 Sheep
6.5.1 Global Sheep Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.6 Mouse
6.6.1 Global Mouse Market Estimates And Forecasts, 2018 – 2030 (USD Million)
6.7 Others
6.7.1 Global Others Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 7 Polyclonal Antibodies Market: End-User Estimates & Trend Analysis
7.1 End-User Movement Analysis & Market Share, 2022 & 2030
7.2 Polyclonal Antibodies Market Estimates & Forecast, By End-User (USD Million)
7.3 Pharmaceutical & Biotechnology Companies
7.3.1 Global Pharmaceutical & Biotechnology Companies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.4 Hospitals & Diagnostic Centers
7.4.1 Global Hospitals & Diagnostic Centers Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.5 Academic & Research Center
7.5.1 Global Academic And Research Center Market Estimates And Forecasts, 2018 – 2030 (USD Million)
Chapter 8 Polyclonal Antibodies Market: Regional Estimates and Trend Analysis
8.1 Polyclonal Antibodies Market: Regional Outlook
8.2 North America
8.2.1 North America Polyclonal Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 Key Country Dynamics
8.2.2.2 Competitive Scenario
8.2.2.3 Regulatory Landscape
8.2.2.4 U.S. Polyclonal Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Key Country Dynamics
8.2.3.2 Competitive Scenario
8.2.3.3 Regulatory Landscape
8.2.3.4 Canada Polyclonal Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3 Europe
8.3.1 Europe Polyclonal Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.3.2 UK
8.3.2.1 Key country dynamics
8.3.2.2 Competitive scenario
8.3.2.3 Regulatory Landscape
8.3.2.4 UK polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Key country dynamics
8.3.3.2 Competitive scenario
8.3.3.3 Regulatory Landscape
8.3.3.4 Germany polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.3.4 France
8.3.4.1 Key country dynamics
8.3.4.2 Competitive scenario
8.3.4.3 Regulatory Landscape
8.3.4.4 France polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Key country dynamics
8.3.5.2 Competitive scenario
8.3.5.3 Regulatory Landscape
8.3.5.4 Italy polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Key country dynamics
8.3.6.2 Competitive scenario
8.3.6.3 Regulatory Landscape
8.3.6.4 Spain polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Key country dynamics
8.3.7.2 Competitive scenario
8.3.7.3 Regulatory Landscape
8.3.7.4 Denmark polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Key country dynamics
8.3.8.2 Competitive scenario
8.3.8.3 Regulatory Landscape
8.3.8.4 Sweden polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Key country dynamics
8.3.9.2 Competitive scenario
8.3.9.3 Regulatory Landscape
8.3.9.4 Norway polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Polyclonal Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.4.2 China
8.4.2.1 Key country dynamics
8.4.2.2 Competitive scenario
8.4.2.3 Regulatory Landscape
8.4.2.4 China polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.4.3 Japan
8.4.3.1 Key country dynamics
8.4.3.2 Competitive scenario
8.4.3.3 Regulatory Landscape
8.4.3.4 Japan polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.4.4 India
8.4.4.1 Key country dynamics
8.4.4.2 Competitive scenario
8.4.4.3 Regulatory Landscape
8.4.4.4 India polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.4.5 South Korea
8.4.5.1 Key country dynamics
8.4.5.2 Competitive scenario
8.4.5.3 Regulatory Landscape
8.4.5.4 South Korea polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.4.6 Australia
8.4.6.1 Key country dynamics
8.4.6.2 Competitive scenario
8.4.6.3 Regulatory Landscape
8.4.6.4 Australia polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.4.7 Thailand
8.4.7.1 Key country dynamics
8.4.7.2 Competitive scenario
8.4.7.3 Regulatory Landscape
8.4.7.4 Thailand polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Polyclonal Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Key country dynamics
8.5.2.2 Competitive scenario
8.5.2.3 Regulatory Landscape
8.5.2.4 Brazil polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Key country dynamics
8.5.3.2 Competitive scenario
8.5.3.3 Regulatory Landscape
8.5.3.4 Mexico polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Key country dynamics
8.5.4.2 Competitive scenario
8.5.4.3 Regulatory Landscape
8.5.4.4 Argentina polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.6 MEA
8.6.1 MEA Polyclonal Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 Key country dynamics
8.6.2.2 Competitive scenario
8.6.2.3 Regulatory Landscape
8.6.2.4 South Africa polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Key country dynamics
8.6.3.2 Competitive scenario
8.6.3.3 Regulatory Landscape
8.6.3.4 Saudi Arabia polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.6.4 UAE
8.6.4.1 Key country dynamics
8.6.4.2 Competitive scenario
8.6.4.3 Regulatory Landscape
8.6.4.4 UAE polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Key country dynamics
8.6.5.2 Competitive scenario
8.6.5.3 Regulatory Landscape
8.6.5.4 Kuwait polyclonal antibodies market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 9 Polyclonal Antibodies Market: Competitive Landscape
9.1 Participant Categorization
9.1.1 THERMO FISHER SCIENTIFIC INC.
9.1.1.1 Overview
9.1.1.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.1.3 Product Benchmarking
9.1.1.4 Strategic Initiatives
9.1.2 MERCK KGAA
9.1.2.1 Overview
9.1.2.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.2.3 Product Benchmarking
9.1.2.4 Strategic Initiatives
9.1.3 ABCAM PLC.
9.1.3.1 Overview
9.1.3.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.3.3 Product Benchmarking
9.1.3.4 Strategic Initiatives
9.1.4. PROTEOGENIX
9.1.4.1 Overview
9.1.4.2 Product Benchmarking
9.1.4.3 Strategic Initiatives
9.1.5. PROTEINTECH GROUP, INC.
9.1.5.1 Overview
9.1.5.2 Product Benchmarking
9.1.5.3 Strategic Initiatives
9.1.6. BIO-RAD LABORATORIES INC.
9.1.6.1 Overview
9.1.6.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.6.3 Product Benchmarking
9.1.6.4 Strategic Initiatives
9.1.7. BPS BIOSCIENCE, INC.
9.1.7.1 Overview
9.1.7.2 Product Benchmarking
9.1.7.3 Strategic Initiatives
9.1.8. R&D SYSTEMS, INC.
9.1.8.1 Overview
9.1.8.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.8.3 Product Benchmarking
9.1.8.4 Strategic Initiatives
9.1.9. AGILENT TECHNOLOGIES, INC.
9.1.9.1 Overview
9.1.9.2 Product Benchmarking
9.1.9.3 Strategic Initiatives
9.1.10. ATLAS ANTIBODIES
9.1.10.1 Overview
9.1.10.2 Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.10.3 Product Benchmarking
9.1.10.4 Strategic Initiatives
9.1.11. CUSABIO TECHNOLOGY LLC
9.1.11.1 Overview
9.1.11.2 Product Benchmarking
9.1.11.3 Strategic Initiatives
9.1.12. ROCKLAND IMMUNOCHEMICALS, INC.
9.1.12.1 Overview
9.1.12.2 Product Benchmarking
9.1.12.3 Strategic Initiatives
9.2 Participant’s Overview
9.3 Financial Performance
9.4 Product Benchmarking
9.5 Company Market Share Analysis, 2022
9.6 Strategy Mapping
9.6.1 Expansion
9.6.2 Acquisition
9.6.3 Product/Service Launch
Chapter 10 Analyst View

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global polyclonal antibodies market, by region, 2018 - 2030 (USD Million)
Table 4 Global polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 5 Global polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 6 Global polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 7 Global polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 8 North America polyclonal antibodies market, by country, 2018 - 2030 (USD Million)
Table 9 North America polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 10 North America polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 11 North America polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 12 North America polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 13 U.S. polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 14 U.S. polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 15 U.S. polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 16 U.S. polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 17 Canada polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 18 Canada polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 19 Canada polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 20 Canada polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 21 Europe polyclonal antibodies market, by country, 2018 - 2030 (USD Million)
Table 22 Europe polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 23 Europe polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 24 Europe polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 25 Europe polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 26 Germany polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 27 Germany polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 28 Germany polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 29 Germany polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 30 UK polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 31 UK polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 32 UK polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 33 UK polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 34 France polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 35 France polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 36 France polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 37 France polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 38 Italy polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 39 Italy polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 40 Italy polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 41 Italy polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 42 Spain polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 43 Spain polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 44 Spain polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 45 Spain polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 46 Denmark polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 47 Denmark polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 48 Denmark polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 49 Denmark polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 50 Sweden polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 51 Sweden polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 52 Sweden polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 53 Sweden polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 54 Norway polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 55 Norway polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 56 Norway polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 57 Norway polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 58 Asia Pacific polyclonal antibodies market, by country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 60 Asia Pacific polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 61 Asia Pacific polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 62 Asia Pacific polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 63 Japan polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 64 Japan polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 65 Japan polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 66 Japan polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 67 China polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 68 China polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 69 China polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 70 China polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 71 India polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 72 India polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 73 India polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 74 India polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 75 Australia polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 76 Australia polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 77 Australia polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 78 Australia polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 79 South Korea polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 80 South Korea polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 81 South Korea polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 82 South Korea polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 83 Thailand polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 84 Thailand polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 85 Thailand polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 86 Thailand polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 87 LATAM polyclonal antibodies market, by country, 2018 - 2030 (USD Million)
Table 88 LATAM polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 89 LATAM polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 90 LATAM polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 91 LATAM polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 92 Brazil polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 93 Brazil polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 94 Brazil polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 95 Brazil polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 96 Mexico polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 97 Mexico polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 98 Mexico polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 99 Mexico polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 100 Argentina polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 101 Argentina polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 102 Argentina polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 103 Argentina polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 104 MEA polyclonal antibodies market, by country, 2018 - 2030 (USD Million)
Table 105 MEA polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 106 MEA polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 107 MEA polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 108 MEA polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 109 South Africa polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 110 South Africa polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 111 South Africa polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 112 South Africa polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 117 UAE polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 118 UAE polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 119 UAE polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 120 UAE polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 121 Kuwait polyclonal antibodies market, by product, 2018 - 2030 (USD Million)
Table 122 Kuwait polyclonal antibodies market, by application, 2018 - 2030 (USD Million)
Table 123 Kuwait polyclonal antibodies market, by source, 2018 - 2030 (USD Million)
Table 124 Kuwait polyclonal antibodies market, by end-user, 2018 - 2030 (USD Million)
Table 125 Company Overview
Table 126 Financial Performance
Table 127 Product Benchmarking
Table 128 Strategic Initiatives

★調査レポート[世界のポリクローナル抗体市場2023-2030：製品別（一次、二次）、用途別（生物医学研究、診断）、由来別（ウサギ、ヤギ）、エンドユーザー別、地域別] (コード：GRV23JUN089)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のポリクローナル抗体市場2023-2030：製品別（一次、二次）、用途別（生物医学研究、診断）、由来別（ウサギ、ヤギ）、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の哺乳類ポリクローナルIgG抗体市場2023-2030：種類別（ネズミ、ウサギ）、製品別（心臓、代謝）、用途別（ウェスタンブロッティング、ELISA）、エンドユーザー別
  • 世界のカスタム抗体市場2023-2030：種類別（モノクローナル）、サービス別（抗体開発）、ソース別（ネズミ）、用途別、エンドユーザー別、地域別
  • 世界の抗体受託開発・製造機関市場2023-2030：製品別、供給源別、治療領域別（腫瘍学、神経学、心臓病学）、エンドユーザー別、地域別
  • 世界の免疫組織化学市場2023-2030：製品別（抗体、試薬、キット）、用途別（診断、研究）、エンドユーザー別、地域別
  • 世界のがん免疫治療薬市場2023-2030：製品別（モノクローナル抗体、免疫調節剤）、用途別、流通チャネル別、エンドユーザー別、地域別
  • 世界のウェアラブルインジェクター市場2024-2030：種類別（オンボディ、オフボディ）、技術別（スプリングベース、モーター駆動）、エンドユーザー別（病院、クリニック）、用途別（腫瘍学）、地域別
  • 世界のデジタル治療（DTx）市場2024-2030：用途別（糖尿病、肥満、禁煙、呼吸器疾患）、エンドユーザー別（患者、医療提供者、支払者、雇用者）、地域別
  • 世界のがん免疫療法市場2024-2030：製品別、用途別、流通別（病院薬局、小売薬局、オンライン薬局）、エンドユーザー別、地域別
  • 世界の無血清培地市場2023-2030：製品別（CHO培地、HEK 293培地、BHK培地、Vero培地）、用途別、種類別、エンドユーザー別、地域別
  • 世界の乳房再建市場2023-2030：製品別（インプラント、組織拡張器）、形状別（円形、解剖学的）、エンドユーザー別（病院、美容クリニック）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆